年龄在青少年特发性关节炎的风湿病学治疗延迟中的作用。
The Role of Age in Delays to Rheumatological Care in Juvenile Idiopathic Arthritis.
机构信息
S.J.W. Shoop-Worrall, PhD, MSc, Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, and Centre for Health Informatics, The University of Manchester;
L. Moull, MBChB, School of Medical Sciences, The University of Manchester.
出版信息
J Rheumatol. 2022 Sep;49(9):1037-1041. doi: 10.3899/jrheum.211316. Epub 2022 Apr 1.
OBJECTIVE
To investigate the relationship between age and symptom duration at initial presentation to pediatric rheumatology for juvenile idiopathic arthritis (JIA).
METHODS
In children and young people (CYP) enrolled in the Childhood Arthritis Prospective Study prior to March 2018, an association between age at presentation (< 5, 5-11, and > 11 yrs) and symptom duration was tested by multivariable linear regression.
RESULTS
In 1577 CYP, 5- to 11-year-olds took 3.2 months longer and > 11-year-olds 6.9 months longer to reach pediatric rheumatology than < 5-year-olds.
CONCLUSION
Adolescents take longer to reach pediatric rheumatology, potentially affecting their longer-term outcomes given the window of opportunity for JIA treatment.
目的
探讨儿童幼年特发性关节炎（JIA）初诊时年龄与症状持续时间的关系。
方法
在 2018 年 3 月前入组儿童关节炎前瞻性研究的儿童和青少年（CYP）中，采用多变量线性回归分析年龄（< 5 岁、5-11 岁和 > 11 岁）与症状持续时间之间的相关性。
结果
在 1577 名 CYP 中，5-11 岁的儿童比 < 5 岁的儿童到达儿科风湿病科的时间延长了 3.2 个月，> 11 岁的儿童延长了 6.9 个月。
结论
青少年到达儿科风湿病科的时间更长，这可能会影响他们的长期预后，因为 JIA 治疗的机会窗口。
Zotero 插件